Mark Dolliver's Takes: Big Pharma Is Shifty

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

When people bad-mouth the drug companies—and when do they not?—the word “greedy” figures prominently in their vocabulary. To focus on that one line of complaint, though, is to miss the breadth of public hostility: Consumers think Big Pharma is shifty as well as greedy.

Polling conducted by Harris Interactive for the Pharmaceutical Safety Institute documents the degree to which people don’t trust the industry to disclose bad news about its wares.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in